Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis.
Coerver E, Schoof L, Hogenboom L, Wessels M, van Ruyven P, van Samkar A, Mostert J, van Kempen Z, van Oosten BW, Wokke BH, Tallantyre E, Myhr KM, Torkildsen O, Killestein J, Smets I, Strijbis E. Coerver E, et al. Among authors: tallantyre e. Mult Scler Relat Disord. 2024 Nov;91:105900. doi: 10.1016/j.msard.2024.105900. Epub 2024 Sep 28. Mult Scler Relat Disord. 2024. PMID: 39369631 Free article.
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies.
Beesley R, Cauchi M, Davies L, Upcott M, Norton E, Loveless S, Anderson V, Wynford-Thomas R, Pickersgill TP, Uzochukwu E, Wardle M, Robertson NP, Tallantyre E, Willis MD. Beesley R, et al. Among authors: tallantyre e. Mult Scler Relat Disord. 2022 Dec;68:104121. doi: 10.1016/j.msard.2022.104121. Epub 2022 Aug 17. Mult Scler Relat Disord. 2022. PMID: 36088727 Free PMC article.
An observational study of alemtuzumab following fingolimod for multiple sclerosis.
Willis M, Pearson O, Illes Z, Sejbaek T, Nielsen C, Duddy M, Petheram K, van Munster C, Killestein J, Malmeström C, Tallantyre E, Robertson N. Willis M, et al. Among authors: tallantyre e. Neurol Neuroimmunol Neuroinflamm. 2017 Jan 10;4(2):e320. doi: 10.1212/NXI.0000000000000320. eCollection 2017 Mar. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28101520 Free PMC article.
A web-based life-style, exercise and activity intervention for people with progressive multiple sclerosis: Results of a single-arm feasibility study.
Busse M, Playle R, Latchem-Hastings J, Button K, Lowe R, Barlow C, Lloyd B, Dean-Young A, Poile V, Dawes H, Davies F, O'Halloran R, Tallantyre E, Edwards A, Wood F, Jones F. Busse M, et al. Among authors: tallantyre e. Mult Scler Relat Disord. 2022 Jan;57:103388. doi: 10.1016/j.msard.2021.103388. Epub 2021 Nov 8. Mult Scler Relat Disord. 2022. PMID: 35158478
88 results